Our insights into the suppressive mechanisms of T1D may lead to prophylactic and therapeutic applications such as using trehalose and Ruminococcus strains as a prebiotic and probiotic, respectively, as well as cell transfer of autologous CD8+ Treg cells differentiated from induced pluripotent stem cells. Here, CD8A is linked to type 1 diabetes mellitus.